GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra
GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra Yahoo/Fly on the Wall
View ArticleTop 20 biotech licensing deals in H1 2012
Top 20 biotech licensing deals in H1 2012 Fierce Biotech
View ArticleBiotech Portfolio Update: 2012 Summary And 2013 Outlook
Biotech Portfolio Update: 2012 Summary And 2013 Outlook Seeking Alpha
View ArticleGenmab Rises as Danske Sees FDA Breakthrough: Copenhagen Mover
Genmab Rises as Danske Sees FDA Breakthrough: Copenhagen Mover Bloomberg
View ArticleNew anti-inflammatory causes stir at ACC
New anti-inflammatory causes stir at ACC Pharma Times, UK
View ArticleGenmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover Bloomberg
View ArticleGenmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug Bloomberg
View ArticleJohnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its...
Johnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its Competitors Seeking Alpha
View ArticleGenmab shares tumble after fund sells shares
Genmab shares tumble after fund sells shares Reuters
View ArticleThese 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation Motley Fool
View ArticleBreakthrough status for GSK and Genmab leukemia drug
Breakthrough status for GSK and Genmab leukemia drug Pharma Times, UK
View ArticleIs the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? Motley Fool
View ArticleGSK and Genmab Announce European Submission to Regulatory Authorities for...
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) Yahoo/Globe Newswire
View ArticleGenmab announces positive results for sclerosis drug candidate
Genmab announces positive results for sclerosis drug candidate Reuters
View ArticleGSK/Genmab file Arzerra for first-line CLL
GSK/Genmab file Arzerra for first-line CLL Pharma Times, UK
View ArticleMilestone payment triggers Genmab guidance increase
Milestone payment triggers Genmab guidance increase Yahoo/Reuters
View ArticleDenmark's Genmab expands biotech collaboration with Janssen
Denmark's Genmab expands biotech collaboration with Janssen Reuters
View ArticleGenmab earnings boosted by Janssen collaboration
Genmab earnings boosted by Janssen collaboration Yahoo/Reuters
View ArticleGlaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint The Fly on the Wall
View ArticleJ&J hands over $25M milestone for daratumumab progress
J&J hands over $25M milestone for daratumumab progress Fierce Biotech
View Article
